NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 315 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,357,775 | +29.0% | 234,074 | +41.9% | 0.01% | +25.0% |
Q2 2023 | $8,027,002 | +3266.2% | 164,961 | +3740.8% | 0.00% | – |
Q1 2023 | $238,458 | -99.8% | 4,295 | -99.6% | 0.00% | -100.0% |
Q4 2021 | $109,021,000 | -8.1% | 1,167,369 | +9.7% | 0.04% | -13.3% |
Q3 2021 | $118,585,000 | -0.8% | 1,064,117 | +1.1% | 0.04% | -2.2% |
Q2 2021 | $119,495,000 | +14.7% | 1,052,542 | +2.6% | 0.05% | +9.5% |
Q1 2021 | $104,206,000 | +14.1% | 1,026,262 | +11.8% | 0.04% | +7.7% |
Q4 2020 | $91,337,000 | +256.2% | 917,772 | +158.6% | 0.04% | +225.0% |
Q3 2020 | $25,640,000 | +194.4% | 354,929 | -63.4% | 0.01% | +200.0% |
Q4 2017 | $8,708,000 | -35.2% | 968,625 | -7.1% | 0.00% | -42.9% |
Q3 2017 | $13,436,000 | +18.7% | 1,042,325 | 0.0% | 0.01% | +16.7% |
Q2 2017 | $11,320,000 | +22.4% | 1,042,325 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $9,245,000 | -24.4% | 1,042,325 | -0.2% | 0.01% | -16.7% |
Q4 2016 | $12,235,000 | -11.7% | 1,044,858 | -16.2% | 0.01% | -14.3% |
Q3 2016 | $13,853,000 | -7.9% | 1,246,858 | 0.0% | 0.01% | -12.5% |
Q2 2016 | $15,043,000 | -2.2% | 1,246,858 | -22.8% | 0.01% | 0.0% |
Q1 2016 | $15,378,000 | -30.2% | 1,615,328 | -20.8% | 0.01% | -27.3% |
Q4 2015 | $22,035,000 | +26.0% | 2,040,328 | +26.6% | 0.01% | +22.2% |
Q3 2015 | $17,492,000 | – | 1,612,170 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |